Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy

被引：6

作者：

Stefan, Gabriel ^{[1
,2
]}

Zugravu, Adrian ^{[1
,2
]}

Stancu, Simona ^{[1
,2
]}

机构：

[1] Univ Med & Pharm Carol Davila, Bucharest, Romania

[2] Dr Carol Davila Teaching Hosp Nephrol, Romanian Renal Registry, St Calea Grivitei 4, Bucharest 010731, Romania

来源：

JOURNAL OF NEPHROLOGY | 2023年 / 36卷 / 02期

关键词：

High risk primary PLA2R positive membranous nephropathy; Intravenous cyclophosphamide; Cyclic steroid-oral cyclophosphamide;

D O I：

10.1007/s40620-022-01426-6

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：293 / 295

页数：3

共 5 条

[1] Substitution of Oral for Intravenous Cyclophosphamide in Membranous Nephropathy [J].

Luzardo, Leonella ;

Ottati, Gabriela ;

Cabrera, Jimena ;

Trujillo, Hernando ;

Garau, Mariela ;

Bedat, Carlota Gonzalez ;

Coitino, Ruben ;

Aunchayna, Maria H. ;

Santiago, Jose ;

Baldovinos, Graciela ;

Silvarino, Ricardo ;

Ferreiro, Alejandro ;

Gonzalez-Martinez, Francisco ;

Gadola, Liliana ;

Noboa, Oscar ;

Caorsi, Hena .

KIDNEY360, 2020, 1 (09) :943-949

[2] Intravenous cyclophosphamide and oral prednisolone is a safe and effective treatment option for idiopathic membranous nephropathy [J].

Mathrani, Vinod ;

Alejmi, Abdulfattah ;

Griffin, Sian ;

Roberts, Gareth .

CLINICAL KIDNEY JOURNAL, 2017, 10 (04) :450-454

[3] KDIGO 2021 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF GLOMERULAR DISEASES [J].

Rovin, Brad H. ;

Adler, Sharon G. ;

Barratt, Jonathan ;

Bridoux, Frank ;

Burdge, Kelly A. ;

Chan, Tak Mao ;

Cook, H. Terence ;

Fervenza, Fernando C. ;

Gibson, Keisha L. ;

Glassock, Richard J. ;

Jayne, David R. W. ;

Jha, Vivekanand ;

Liew, Adrian ;

Liu, Zhi-Hong ;

Mejia-Vilet, Juan M. ;

Nester, Carla M. ;

Radhakrishnan, Jai ;

Rave, Elizabeth M. ;

Reich, Heather N. ;

Ronco, Pierre ;

Sanders, Jan-Stephan F. ;

Sethi, Sanjeev ;

Suzuki, Yusuke ;

Tang, Sydney C. W. ;

Tesar, Vladimir ;

Vivarelli, Marina ;

Wetzels, Jack F. M. ;

Lytvyn, Lyubov ;

Craig, Jonathan C. ;

Tunnicliffe, David J. ;

Howell, Martin ;

Tonelli, Marcello A. ;

Cheung, Michael ;

Earley, Amy ;

Floege, Juergen .

KIDNEY INTERNATIONAL, 2021, 100 (04) :S1-S276

[4] Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial [J].

Scolari, Francesco ;

Delbarba, Elisa ;

Santoro, Domenico ;

Gesualdo, Loreto ;

Pani, Antonello ;

Dallera, Nadia ;

Mani, Laila-Yasmin ;

Santostefano, Marisa ;

Feriozzi, Sandro ;

Quaglia, Marco ;

Boscutti, Giuliano ;

Ferrantelli, Angelo ;

Marcantoni, Carmelita ;

Passerini, Patrizia ;

Magistroni, Riccardo ;

Alberici, Federico ;

Ghiggeri, Gian Marco ;

Ponticelli, Claudio ;

Ravani, Pietro .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (04) :972-982

[5] Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy [J].

Stefan, Gabriel ;

Stancu, Simona ;

Zugravu, Adrian ;

Popa, Otilia ;

Zubidat, Dalia ;

Petre, Nicoleta ;

Mircescu, Gabriel .

RENAL FAILURE, 2022, 44 (01) :258-268

← 1 →